GSK plc (GSK) News
Track canonical SquawkNews coverage tagged to GSK, GSK plc. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 25 indexed stories across 13 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. re
EARNINGS | Aug 11, 2026, 12:39 PM UTC
H
Watching SCYNEXIS; Shares Trading Higher, Hearing GSK Is Close To Relaunching BREXAFEMME With The Co, FDA Updates BREXAFEMME Label With Pedi
Watching SCYNEXIS; Shares Trading Higher, Hearing GSK Is Close To Relaunching BREXAFEMME With The Co, FDA Updates BREXAFEMME Label With Pediatric Use Information And Revised Patient Safety Guidance
REGULATION | Jul 31, 2026, 04:04 PM UTC
M
GSK uses AI to speed up drug development
GSK uses AI for faster drug development
EQUITY | Jul 30, 2026, 10:29 AM UTC
L
GSK GSK: viiv cabenuva (cab+rpv La) Superior to daily oral therapy in adolescents with hiv, lata week 96 results - press release
GSK GSK: viiv cabenuva (cab+rpv La) Superior to daily oral therapy in adolescents with hiv, lata week 96 results - press release
EQUITY | Jul 29, 2026, 02:22 PM UTC
L
GSK Races To Protect Profits Before Its HIV Blockbuster Faces Generic Rivals
GSK Plc (NYSE: GSK ) stock rose Tuesday after the British drugmaker reported better-than-expected second-quarter results. Launches $2.52 Billion Cost-Savings Program GSK said its new Accelerate Growth program targets 1.9
EARNINGS | Jul 28, 2026, 05:30 PM UTC
H
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on Tuesday. Shares of Sherwin-Williams Co (NYSE: SHW ) rose sharply after the company reported better-than-expected second-quarter financial resu
EARNINGS | Jul 28, 2026, 02:05 PM UTC
H
Morning Movers: Corning sinks and Boeing gains after quarterly results
Stock futures are mixed this morning as investors brace for a pivotal stretch of earnings and the start of the Federal Reserve's two-day policy meeting, with renewed concerns over artificial intelligence spending and ris
EARNINGS | Jul 28, 2026, 01:00 PM UTC
L
GSK CEO- about 45% of savings will come from better procurement - Media call GSK CFO - we are using AI and tech as big enabler for process c
GSK CEO- about 45% of savings will come from better procurement - Media call GSK CFO - we are using AI and tech as big enabler for process changes across organisation- Media call GSK CEO on cambridge investment notes we
RATES | Jul 28, 2026, 11:53 AM UTC
L
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. re
RATES | Jul 28, 2026, 11:38 AM UTC
L
GSK sees FY26 core EPS growth 7%-9%
Expect 2026 turnover...
EARNINGS | Jul 28, 2026, 11:36 AM UTC
L
GSK Affirms FY2026 Adj EPS Guidance of $4.90-$5.00 vs $4.79 Est; Affirms FY2026 Sales Guidance of $44.754B vs $45.690B Est
GSK (NYSE: GSK ) affirms FY2026 Adj EPS guidance from $4.90-$5.00 to $4.90-$5.00 vs $4.79 analyst estimate. Affirms FY2026 sales outlook from $44.754 billion to $44.754 billion vs $45.690 billion estimate.
EARNINGS | Jul 28, 2026, 11:19 AM UTC
L
GSK GSK RESULTS: Q2, Q2 sales GBP 8.409B vs. EST GBP 8.239B, Q2 ADJ operating profit GBP 2.800B vs. EST GBP 2.646B, Q2 ADJ EPS GBP 0.505 vs.
GSK GSK RESULTS: Q2, Q2 sales GBP 8.409B vs. EST GBP 8.239B, Q2 ADJ operating profit GBP 2.800B vs. EST GBP 2.646B, Q2 ADJ EPS GBP 0.505 vs. EST GBP 0.46, Q2 dividend GBP 0.17, GSK Earnings Notes:, Outlook FY core operat
EARNINGS | Jul 28, 2026, 11:00 AM UTC
L
NUVB Maintain Market Outperform, $10 PT after GSK FDA approval @ Citizens
NUVB Maintain Market Outperform, $10 PT after GSK FDA approval @ Citizens
REGULATION | Jul 23, 2026, 11:19 AM UTC
L
GSK reports Jideytro approved by FDA for ROS1-positive NSCLC
GSK announced the U.S....
REGULATION | Jul 22, 2026, 04:43 PM UTC
H
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled. IMPORTED GENERIC DRUGS: U.S.
GEOPOLITICS | Jul 22, 2026, 02:08 PM UTC
H
Watch possibly MRK JNJ LLY PFE SNY AZN GSK NVS BMY RHHB after Trump post last night on generic drugs, and 100% tariff brought into US
Watch possibly MRK JNJ LLY PFE SNY AZN GSK NVS BMY RHHB after Trump post last night on generic drugs, and 100% tariff brought into US
GEOPOLITICS | Jul 22, 2026, 10:50 AM UTC
H
Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028
U.S. President Donald...
GEOPOLITICS | Jul 21, 2026, 11:03 PM UTC
L
GSK's ViiV Healthcare to present new data on INSTI-focused portfolio
GSK's ViiV Healthcare to present new data on INSTI-focused portfolio
EQUITY | Jul 21, 2026, 01:26 PM UTC
L
TRVI View GSK's decision to halt camlipixant in RCC as a positive for TRVI, ending the P2X3 class and leaving Haduvio the leading differenti
TRVI View GSK's decision to halt camlipixant in RCC as a positive for TRVI, ending the P2X3 class and leaving Haduvio the leading differentiated candidate; Briley reiterate Buy and raise PT to $31 from $21 @ Briley
EQUITY | Jul 20, 2026, 01:09 PM UTC
L
GSK Plc - bexsero 1-dose booster EMA file Acceptance GSK - EMA accepts submission to update bexsero label for 1-dose booster in 10+ year old
GSK Plc - bexsero 1-dose booster EMA file Acceptance GSK - EMA accepts submission to update bexsero label for 1-dose booster in 10+ year olds GSK Plc - bexsero 1-dose booster EMA file Acceptance
EQUITY | Jul 20, 2026, 10:45 AM UTC
L
TRVI highs up around 12%, benefiting from GSK stopping its Chronic cough study
TRVI highs up around 12%, benefiting from GSK stopping its Chronic cough study
EQUITY | Jul 17, 2026, 02:08 PM UTC
L
GSK said it decided to halt the development of an experimental drug as a treatment for chronic cough after the Medicine missed the key goal
GSK said it decided to halt the development of an experimental drug as a treatment for chronic cough after the Medicine missed the key goal in a late-stage clinical study; said the drug, camlipixant, achieved mixed resul
EQUITY | Jul 17, 2026, 10:15 AM UTC
L
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. re
RATES | Jul 14, 2026, 11:30 AM UTC
H
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Analysts' ratings for high-yielding health care stocks: Viatris, Medtronic, and GSK.
EQUITY | Jun 29, 2026, 11:46 AM UTC
M
GSK: Tender Offer Expires 7/14
GSK's tender offer for NUVL is set to expire on July 14
EQUITY | Jun 24, 2026, 12:02 PM UTC